Showing 3851-3860 of 7368 results for "".
- FDA Advisory Arm Recommends Brodalumab For Moderate-To-Severe Plaque Psoriasishttps://practicaldermatology.com/news/fda-advisory-arm-recommends-brodalumab-for-moderate-to-severe-plaque-psoriasis/2458497/A US. Food and Drug Administration (FDA) advisory panel voted to greenlight Valeant’s IL-17 blocker brodalumab for the treatment of moderate-to-severe plaque psoriasis in adults. The committee voted 18 to 0 in favor of brodalumab injection, 210
- Cynosure Receives Health Canada Authorization to Market SculpSure®https://practicaldermatology.com/news/cynosure-receives-health-canada-authorization-to-market-sculpsure/2458503/Cynosure, Inc. received Health Canada Authorization to Market SculpSure® for non-invasive lipolysis of the abdomen and flanks. SculpSure is a fat-reduction laser intended for individuals with a body mass index (BMI) of 30 or less. The
- New International Index Suggests Skin Cancer More Prevalent in Developed Countrieshttps://practicaldermatology.com/news/new-international-index-suggests-skin-cancer-more-prevalent-in-developed-countries/2458504/The USA has the 9th highest diagnoses of skin cancer per capita annually, according to a new report from Derma.plus. New Zealand had the most cases of skin cancer per capita followed by Australia, Switzerland, Sweden, and
- Topix Pharmaceuticals Partners with New Mountain Capitalhttps://practicaldermatology.com/news/new-mountain-capital-partners-with-topix-pharmaceuticals/2458505/Topix Pharmaceuticals, Inc. has partnered with New Mountain Capital, LLC, a growth-oriented investment firm that currently manages over $15 billion in assets. New Mountain, a New York-based private equity firm, identified Topix through a proactive focus in the life sciences and aestheti
- Study: Primary Care Melanoma Screening Does Not Lead to Overtreatmenthttps://practicaldermatology.com/news/study-primary-care-melanoma-screening-does-not-lead-to-overtreatment/2458506/Melanoma screening in primary care practice does not lead to overtreatment, new research suggests. In the new study, primary care providers at the University of Pittsburgh Medical Center system received online training in melanoma screening and began looking for the skin cancers in
- Virtual Peer Pressure on Social Media May Up Indoor Tanning in Young Womenhttps://practicaldermatology.com/news/virtual-peer-pressure-on-social-media-may-up-indoor-tanning-in-young-women/2458523/Use of Twitter and Instagram may be driving an uptick in indoor tanning among young adult women, a new study suggests. The study, which appears in the July issue of the Journal of the American Academ
- Alopecia Areata May Protect Against Stroke, Heart Attackhttps://practicaldermatology.com/news/alopecia-areata-may-protect-against-stroke-heart-attack/2458522/Unlike other inflammatory dermatologic conditions, alopecia areata does not appear to increase risk for cardiovascular disease, and it may even protect against stroke, new research suggests. Researchers compared 1,377 alopecia areata patients to 4,131 control subjects. They found th
- Free Sunscreen Program Expands in Massachusetts Thanks to $25,000 Gifthttps://practicaldermatology.com/news/free-sunscreen-program-expands-in-mass-thanks-to-25000-gift/2458526/The Melanoma Foundation of New England (MFNE) received a $25,000 gift from the Arbella Insurance Foundation to allow its Practice Safe Skin program
- Preston Romm Joins Suneva Medical As Chief Operating Officerhttps://practicaldermatology.com/news/preston-romm-joins-suneva-medical-as-chief-operating-officer/2458528/Suneva Medical Inc. appointed Preston Romm to chief operating officer (COO). Romm joins Suneva Medical with more than 30 years of experience and will be responsible for leading the company's sales, marketing and operations. Previously serving as president of Oba
- With $25 Million Financing, Suneva Medical Gets Ready to Up Their Gamehttps://practicaldermatology.com/news/with-25-million-financing-suneva-medical-gets-ready-to-up-their-game/2458531/Suneva Medical closed $25 million financing to support continued growth opportunities, the company reports. This financing, which includes $25 million equity investment from Essex Woodlands, strengthens Suneva Medi